High frequency of Parkin exon rearrangements in Mexican-mestizo patients with early-onset Parkinson's disease

Movement Disorders

Volumn 27, Issue 8, 2012, Pages 1047-1051

  Camacho, Jorge Luis Guerrero ^a,b   Jaramillo, Nancy Monroy ^a   Gómez, Petra Yescas ^a   Violante, Mayela Rodríguez ^a   Woehrlen, Catherine Boll ^a   Vilatela, Ma Elisa Alonso ^a   López López, Marisol ^c  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^c DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Exon rearrangements; Mutation; PARK2; Parkin; Parkinson's disease

Indexed keywords

PARKIN;

ADOLESCENT; ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXON; FEMALE; GENE DELETION; GENE DOSAGE; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC CODE; HETEROZYGOSITY; HISPANIC; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN;

ADOLESCENT; ADULT; AGE OF ONSET; DNA; EXONS; FEMALE; GENE DELETION; GENE DOSAGE; GENE FREQUENCY; GENE REARRANGEMENT; HUMANS; INDIANS, CENTRAL AMERICAN; MALE; MEXICO; MIDDLE AGED; MUSCLE RIGIDITY; PARKINSON DISEASE; PEDIGREE; TREMOR; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 84864014036     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25030     Document Type: Article

References (36)

1. Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet. 2004; 363: 1783-1793.
2. Lesage S, Briece A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. 2009; 18: R48-R59.
3. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene: French Parkinson's Disease Genetics Study Group. N Engl J Med. 2000; 342: 1560-1567.
4. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. Database maintained by Cooper DN, Ball EV, Stenson PD, Phillips AD, Shaw K, Mort ME with the assistance of Thomas NST. Cardiff University, 2011. Available at Accessed March 7, 2012.
5. Mitsui J, Takahashi Y, Goto J, et al. Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines. Am J Hum Genet. 2010; 87: 75-89.
6. Shimura H, Hattori N, Kubo Si, et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000; 25: 302-305.
7. Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mut. 2010; 31: 763-780
8. Klein C, Djarmati A, Hedrich K, et al. PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism. Eur J Hum Genet. 2005; 13: 1086-1095.
9. Lesage S, Lohmann E, Tison F, Durif F, Durr A, Brice A. Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls. J Med Genet. 2008; 45: 43-46.
10. Marder KS, Tang MX, Mejia-Santana H, et al. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol. 2010; 67: 731-738.
11. Periquet M, Lücking CV, Vaughan JR, et al. Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects. Am J Hum Genet. 2001; 68: 617-626.
12. Bertoli-Avella AM, Giroud-Benitez JL, Akyol A, et al. Italian Parkinson genetics network. Novel parkin mutations detected in patients with early-onset Parkinson's disease. Mov Disord. 2005; 20: 424-431.
13. Semenova EV, Shadrina MI, Slominsky PA, et al. Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease. Mov Disord. 2012; 27: 139-142.
14. Kim JS, Lee KS, Kim YI, Lee KH. Homozygous exon 4 deletion in Parkin gene in a Korean family with autosomal recessive early onset Parkinsonism. Yonsei Med J. 2003; 44: 336-339.
15. Shyu WC, Lin SZ, Chiang MF, et al. Early-onset Parkinson's disease in a Chinese population: (99m)Tc-TRODAT-1 SPECT, Parkin gene analysis and clinical study. Parkinsonism Relat Disord. 2005; 11: 173-180.
16. Lincoln SJ, Maraganore DM, Lesnick TG, et al. Parkin variants in North American Parkinson's disease: cases and controls. Mov Disord. 2003; 18: 1306-1311.
17. Pankratz N, Kissell DK, Pauciulo MW, et al. Parkinson Study Group-PROGENI Investigators. Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations. Neurology. 2009; 73: 279-286.
18. Deng H, Le WD, Hunter CB, Mejia N, Xie WJ, Jankovic J. A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations. Arch Neurol. 2007; 64: 421-424.
19. Gibb WR. Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgrad Med J. 1988; 64: 345-351.
20. Kitada T, Asakawa S, Hattori N, et al. Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998; 392: 605-608.
21. Mellick GD, Siebert GA, Funayama M, et al. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia. Parkinsonism Relat Disord. 2009; 15: 105-109.
22. Hedrich K, Kann M, Lanthaler AJ, et al. The importance of gene dosage studies: mutational analisis of the parkin gene in early-onset parkinsonism. Hum Mol Genet. 2001; 10: 1649-1656.
23. Periquet M, Latouche M, Lohmann E, et al. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain. 2003; 126: 1271-1278.
24. Hedrich K, Eskelson C, Beth Wilmot, et al. Distribution, type, and origin of parkin mutations: review and case studies. Mov Disord. 2004; 19: 1146-1157.
25. Vinish M, Prabhakar S, Khullar M, Verma I, Anand A. Genetic screening reveals high frequency of PARK2 mutations and reduced parkin expression conferring risk for parkinsonism in North West India. J Neurol Neurosurg Psychiatry. 2010; 81: 166-170.
26. Keyser RJ, Lombard D, Veikondis R, Carr J, Bardien S. Analysis of exon dosage using MLPA in South African Parkinson's disease patients. Neurogenetics. 2010; 11: 305-312.
27. Muñoz E, Tolosa E, Pastor P, et al. Relative high frequency of the c.255delA parkin gene mutation in Spanish patients with autosomal recessive parkinsonism. J Neurol Neurosurg Psychiatry. 2002; 73: 582-584.
28. Periquet M, Lücking CB, Vaughan JR, et al. The French Parkinson's Disease Genetics Study Group, and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects. Am J Hum Genet. 2001; 68: 617-626.
29. Pankratz N, Kisselll DK, Pauciulo MW, et al. Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations. Neurology. 2009; 73: 279-286.
30. Pankratz N, Dumitriu A, Hetrick KN, et al. Copy number variation in familial Parkinson disease. PLoS ONE. 2011; 6: e20988.
31. Kay DM, Stevens CF, Hamza TH, et al. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2. Neurology. 2010; 75: 1189-1194.
32. Brügemann N, Mitterer M, Lanthaler AJ, et al. Frequency of heterozygous parkin mutations in healthy subjects: need for careful prospective follow-up examination of mutation carriers. Parkinsonism Relat Disord. 2009; 15: 425-429.
33. Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol. 2007; 6: 652-662.
34. Um JW, Im E, Lee HJ, et al. Parkin directly modulates 26S proteasome activity. J Neurosci. 2010; 30: 11805-11814.
35. Sang TK, Chang HY, Lawless GM, et al. A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine. J Neurosci. 2007; 27: 981-992.
36. Lu XH, Fleming SM, Meurers B, et al. BAC transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K resistant alpha-synuclein. J Neurosci. 2009; 29: 1962-1976.